Sign Up to like & get
recommendations!
2
Published in 2023 at "Frontiers in Cardiovascular Medicine"
DOI: 10.3389/fcvm.2023.1040834
Abstract: Background Further studies are needed to expand the evidence for the association of rivaroxaban with a lower risk of adverse renal outcomes in patients with atrial fibrillation (AF) as compared with warfarin, especially in Asians.…
read more here.
Keywords:
outcomes rivaroxaban;
kidney;
compared warfarin;
renal outcomes ... See more keywords